2024-08-25 - Analysis Report
## TMO Stock Analysis Report

**Company Overview:** TMO (Thermo Fisher Scientific) is a global leader in providing laboratory and research products and services, serving various industries including pharmaceuticals, life sciences, and diagnostics.

**1. Performance Comparison:**
* **Cumulative Return:** TMO has generated a cumulative return of 95.8%, significantly outperforming the S&P 500 (VOO) which has returned 71.75%.
* **Relative Outperformance:** TMO's relative outperformance compared to VOO stands at 23.95%, which represents 39.74% of the maximum historical outperformance. This indicates that TMO has been consistently outperforming the benchmark over the analyzed period. 

**2. Recent Price Movement:**
* **Closing Price:** 606.12
* **Moving Averages:**
    * 5-day: 608.46
    * 20-day: 605.45
    * 60-day: 574.81

The stock price is currently trading above all three moving averages, indicating a short-term bullish trend.

**3. Technical Indicators:**
* **RSI:** 57.23
* **PPO:** -0.21
* **Delta_Previous_Relative_Divergence:** -7.25

The RSI suggests the stock is neither overbought nor oversold. The PPO is negative, indicating a weakening momentum. The negative Delta_Previous_Relative_Divergence indicates a recent short-term decline in relative outperformance.

**4. Recent Earnings and Outlook:**

| Date        | EPS  | Revenue        |
|-------------|------|----------------|
| 2024-08-02 | 4.05 | 10.54 B$      |
| 2024-05-03 | 3.47 | 10.35 B$      |
| 2023-11-03 | 4.44 | 10.57 B$      |
| 2023-08-04 | 3.53 | 10.69 B$      |
| 2024-08-02 | 3.53 | 10.69 B$      |

The most recent earnings report for the quarter ending August 2024 showed an EPS of 4.05, exceeding analysts' expectations. Revenue was also strong, exceeding 10.54 billion dollars. These strong results indicate a continued positive trajectory for the company.

**5. Overall Analysis:**
TMO is exhibiting a strong performance compared to the benchmark, with a significant cumulative return and consistent outperformance. Recent price action shows a short-term bullish trend, supported by positive earnings results. However, technical indicators suggest a slight weakening momentum and a recent decline in relative outperformance. Overall, TMO remains a strong contender in the market, backed by its robust fundamentals and impressive performance. 

**6. Recommendations:**
* **Short-Term:** Maintain a **Hold** position, considering the recent decline in relative outperformance and the negative PPO signal.
* **Long-Term:** TMO remains a **Buy** due to its strong growth potential, consistent outperformance, and robust earnings performance. 
